Effects of automed sputum aspirating device for the patients with intractable neurological disease using tracheotomy positive pressure ventilation (TPPV) in long-term care bed.

Effects of automed sputum aspirating device for the patients with intractable neurological disease using tracheotomy positive pressure ventilation (TPPV) in long-term care bed. - Effects of automated sputum aspirating device.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015285

Enrollment

Registered

2014-09-30

Start date

2015-03-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intractable neurological disease

Interventions

automed sputum aspirating device

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Duchenn myscular dystrophy, Myotonic dystrophy type 1, Fukuyama congenital muscular dystrophy, Amyotrophic lateral sclerosis, multiple system atrophy Currently hospitalized using tracheotomy positive pressure ventilation 24 hours a day capable of using switch for nurse call twenty and above the study carried out with the informed consent of the patient

Exclusion criteria

Exclusion criteria: A fever over 38 degree celsius Count of leukocyte over 12,000 within 7 days before starting the study Use antibiotics within 7 days before starting the study The decrease of inspiratory pressure is less than 2 hPa after moving the device

Design outcomes

Primary

Measure	Time frame
The value of SpO2, the number of times of respiratory tract infection, the frequency of manual suctioning, and the expense of manual suctioning are evaluated before and after conducting automated sputum aspirating device for three months each other. SF8, a scale of health related quality of life is also measured.	—

Countries

Japan

Contacts

Public ContactTakayasu Fukudome

Nagasaki Kawatana Medical Center Division of clinical medicine

ereking@mua.biglobe.ne.jp0956823121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026